Shortened hemofilter survival time due to lipid infusion in continuous renal replacement therapy
- PMID: 18059111
- DOI: 10.1159/000112043
Shortened hemofilter survival time due to lipid infusion in continuous renal replacement therapy
Abstract
Background: Continuous renal replacement therapy is widely used for the treatment of critically ill patients with acute renal failure in critical care units. The survival time of the extracorporeal circuit is an important factor in providing renal replacement therapy. Despite rigorous efforts to maintain hemofilter patency, clinicians are occasionally faced with an unexplained short circuit survival time.
Methods: We present a critically ill patient undergoing continuous venovenous hemofiltration with regional citrate anticoagulation for management of acute renal failure in the context of sepsis. Once the patient was started on lipid infusion as part of total parenteral nutrition, we observed a shortened circuit survival due to premature hemofilter failure necessitating frequent changes of the hemofilter. The known potential causes for this phenomenon were ruled out.
Results: Evaluation revealed grossly lipemic serum associated with severe hypertriglyceridemia. Discontinuation of the lipid infusion was followed by a rapid return of circuit survival time to its baseline. Evaluation of the hemofilter by electron microscopy revealed that the rapid blockage of the hollow fibers was caused by lipid microparticles and fibrin deposits.
Conclusion: Since total parenteral nutrition is commonly administered to malnourished and hypercatabolic critically ill patients on continuous renal replacement therapy, we suggest that intravenous lipid therapy might be a previously unreported and unappreciated remediable cause of premature hemofilter failure.
(c) 2007 S. Karger AG, Basel.
Similar articles
-
Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy.Nurs Crit Care. 2009 Jul-Aug;14(4):191-9. doi: 10.1111/j.1478-5153.2009.00339.x. Nurs Crit Care. 2009. PMID: 19531037 Review.
-
Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.Crit Care Med. 2009 Feb;37(2):533-8. doi: 10.1097/CCM.0b013e318195424d. Crit Care Med. 2009. PMID: 19114909 Clinical Trial.
-
Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.Ann Pharmacother. 2009 Sep;43(9):1419-25. doi: 10.1345/aph.1M182. Epub 2009 Aug 18. Ann Pharmacother. 2009. PMID: 19690224
-
Prognostic factors in critically ill surgical patients requiring continuous renal replacement therapy.J Nephrol. 2008 Nov-Dec;21(6):909-18. J Nephrol. 2008. PMID: 19034876
-
Recent evolution of renal replacement therapy in the critically ill patient.Crit Care. 2006 Feb;10(1):123. doi: 10.1186/cc4843. Crit Care. 2006. PMID: 16542480 Free PMC article. Review.
Cited by
-
What is this chocolate milk in my circuit? A cause of acute clotting of a continuous renal replacement circuit: Answers.Pediatr Nephrol. 2016 Dec;31(12):2253-2255. doi: 10.1007/s00467-016-3318-4. Epub 2016 Jan 27. Pediatr Nephrol. 2016. PMID: 26817475 Free PMC article. No abstract available.
-
Metabolic disturbances potentially attributable to clogging during continuous renal replacement therapy.Intensive Care Med Exp. 2023 Dec 21;11(1):99. doi: 10.1186/s40635-023-00581-9. Intensive Care Med Exp. 2023. PMID: 38127207 Free PMC article.
-
Hypertriglyceridemia Causing Continuous Renal Replacement Therapy Dysfunction in a Patient with End-stage Liver Disease.Indian J Nephrol. 2018 Jul-Aug;28(4):303-306. doi: 10.4103/ijn.IJN_201_17. Indian J Nephrol. 2018. PMID: 30158750 Free PMC article.
-
Metabolic and nutritional aspects in continuous renal replacement therapy.J Intensive Med. 2023 Jan 30;3(3):228-238. doi: 10.1016/j.jointm.2022.11.001. eCollection 2023 Jul 31. J Intensive Med. 2023. PMID: 37533807 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources